Greenwich LifeSciences, Inc.
Greenwich LifeSciences, Inc. scores highest on Anchor (54) and lowest on Price (1). Its PosiPenta is 38.62 out of 100, weaker than most similar companies.
On the Penta Grid this week, Greenwich LifeSciences, Inc. is Grid #583 of 837 in the Healthcare sector in United States, and Grid #3,007 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Greenwich LifeSciences, Inc. | 38.62 | 1 | 47 | 46 | 45 | 54 |
| Inhibikase Therapeutics, Inc. | 50.89 | 33 | 44 | 59 | 68 | 51 |
| SIGA Technologies, Inc. | 58.32 | 34 | 87 | 32 | 78 | 60 |
| BridgeBio Oncology Therapeutics, Inc. | 41.90 | 43 | 37 | 11 | 55 | 63 |
| TriSalus Life Sciences, Inc. | 35.27 | 1 | 57 | 47 | 4 | 66 |
| Keros Therapeutics, Inc. | 40.42 | 42 | 14 | 39 | 62 | 45 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -9.51 |
| P/B ratio | 68.52 |
EEarnings
| Trailing EPS | ₹-144.91 |
| Forward EPS | ₹-77.67 |
NNitro
| Price | 1378.10 |
| 52-week high | 3229.78 |
| 52-week low | 736.88 |
| Fall from 52-week high | 57.3% |
TTorque
| Return on equity (ROE) | -986.32% |
| Debt-to-equity | 0.00 |
AAnchor
| Beta (price swings) | 1.46 |
| Market cap | ₹2,022 Cr |
| Insider holding | 47.91% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Greenwich LifeSciences, Inc.'s PosiPenta score?
Greenwich LifeSciences, Inc.'s PosiPenta is 38.62 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Greenwich LifeSciences, Inc. stand on the Penta Grid?
On the Penta Grid this week, Greenwich LifeSciences, Inc. is Grid #583 of 837 in the Healthcare sector in United States, and Grid #3,007 of 4,000 in United States.
Which PosiPenta pillar is strongest for Greenwich LifeSciences, Inc.?
Anchor (stability and dividends), with a score of 54 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Greenwich LifeSciences, Inc.?
Price (valuation), with a score of 1 out of 100: much weaker than most similar companies.
Has Greenwich LifeSciences, Inc.'s PosiPenta changed since last week?
Yes, it rose 3.03 points, from 35.59 to 38.62.
PositoAI is for research and education only and is not investment advice.